To BE or to PE: Prime editors provide more choices for epitope-editing-based immunotherapy.

Cell Stem Cell

Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China. Electronic address:

Published: November 2024

Epitope editing is a promising strategy for protecting hematopoietic cells from eradication by immunotherapies. Recently, in Cell Stem Cell, Ji et al. applied both base editing (BE) and prime editing (PE) to alter the epitope of CD123 in hematopoietic stem cells for CAR-T therapy against acute myeloid leukemia..

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stem.2024.10.009DOI Listing

Publication Analysis

Top Keywords

prime editors
4
editors provide
4
provide choices
4
choices epitope-editing-based
4
epitope-editing-based immunotherapy
4
immunotherapy epitope
4
epitope editing
4
editing promising
4
promising strategy
4
strategy protecting
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!